#IMamboforMyeloma is going to #BMTTandem16!
To help raise #MultipleMyeloma awareness among bone and marrow transplant specialist members of the Center for International Bone & Marrow Transplant Research (CIBMTR) and the American Society of Blood & Marrow Transplant (ASBMT), Sanofi Genzyme will raise recognition for the Multiple Myeloma Community at the upcoming #BMTTandem16 Annual Meeting in Honolulu, Hawaii, February 18th through February 22nd.
Sanofi Genzyme will make a $10.00 donation to CIBMTR and ASBMT for every 10 Tweets and Retweets which include the Hashtags #IMambo4Myeloma and #BMTTandem16, starting NOW through February 23rd.. So please start Tweeting and be sure to include the hashtags #IMambo4Myeloma and #BMTTandem16 in each of your tweets and RTs. Follow Sanofi Genzyme on Twitter @SanofiGenzyme
Our #myeloma awareness initiative continues to BUILD a bridge for raising funds!
Sanofi Genzyme developed Isatuximab (SAR 650984) which is another anti-CD38 antibody that has shown single-agent activity in Phase I testing among heavily pre-treated myeloma patients.
There is NO limit to the amount of times you can tweet and retweet this photo and the #IMambo4Myeloma #MBTTandem16 Hashtags! Please HELP !!